Stay updated with breaking news from Trial failures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Was licensed for use in the us earlier this month. it means that after years of trial failures, there are now two treatments that delay the relentless progression of alzheimer s. and surely that paves the way for better drugs down the line. our medical editor fergus walsh has spoken exclusively to one of the patients on the trial. hello. are you all right, mr colley? hi, yes. yes. i ve got your donanemab here for you. mike colley has alzheimer s disease, yet the 80 year old feels incredibly fortunate. i m one of the luckiest people you ll ever meet. just for this. that s because he s been on the global trial of donanemab for two years. he s come with his son for his monthly infusion, at this clinic in london. i seem to get more confident every day. and i m sure this is going to be successful. they ll get all the rubbish off the top of my brain and i ll be back to normality. i m very confident about that. ....
/PRNewswire/ The "Cell Based Assay & High Content Screening Markets. Forecasts by User and Product. With Executive and Consultant Guides. including. ....